Opus Genetics
IRD
35 hedge funds and large institutions have $5.32M invested in Opus Genetics in 2015 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding
Funds holding: 35 → 35 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
11% less capital invested
Capital invested by funds: $5.94M → $5.32M (-$626K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$202K |
| 2 |
HVIA
Hudson Valley Investment Advisors
Goshen,
New York
|
+$142K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$121K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$89.3K |
| 5 |
AT
Arden Trust
Wilmington,
Delaware
|
+$35.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$73.7K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$37K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$27.2K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$8.83K |
IRD Hedge Fund Activity: Q2 2015 in Review
35 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q2 2015, worth a combined $5.32M — down 11% from $5.94M a quarter earlier.
Fund positioning in IRD was balanced in Q2 2015: 5 funds opened new positions, 5 closed out, 7 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $202K. The largest seller was AQR Capital Management, cutting an estimated $73.7K.
- 35 institutional investors held Opus Genetics (IRD) as of Q2 2015, unchanged from Q1 2015.
- Funds reported $5.32M of Opus Genetics stock for Q2 2015, down 11% quarter-over-quarter.
- 5 funds opened new Opus Genetics positions in Q2 2015 and 5 closed out, a net change of 0 holders.
- The largest Opus Genetics buyer in Q2 2015 was Renaissance Technologies, an estimated $202K added.
- The largest Opus Genetics seller in Q2 2015 was AQR Capital Management, an estimated $73.7K sold.
Based on aggregated 13F filings for Q2 2015.